-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Eterna Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Eterna Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -4.92 USD/shares, a 378% decline year-over-year.
- Eterna Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -8.31 USD/shares, a 116% decline year-over-year.
- Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -4.08 USD/shares, a 49.4% increase from 2022.
- Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -8.06 USD/shares, a 85.8% increase from 2021.
- Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -56.6 USD/shares, a 13707% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)